Related News
China still lags behind in colorectal cancer screening: experts
Online Edition
EARLY screening is the most effective measure to detect colorectal cancer and reduce its incidence and mortality. However, its screening lags behind in China with about 60 percent of patients diagnosed of the disease until after middle or terminal stage, medical experts said.
The five-year survival for colorectal cancer patients is only 31 percent in China, while it is 67 percent in the United States, whose incidence and mortality keep dropping by 3 percent annually since 2001 because of wide coverage of screening, experts said while releasing a scientific promotion book on colorectal cancer prevention and control launched by Team Curis Group and Pineapple Health Studio.
Due to the rise of elderly population and changing lifestyle, people with colorectal cancer have been rising in China and it has become No.5 most prevalent and deadly cancer. It is estimated that China will have 480,000 new patients every year from 2035.
“Early screening and early treatment are the key, especially among those with high risk,” said Dr Wang Jiejun from Shanghai Changzheng Hospital.
Concerning to people’s reluctance of receiving colonscopy and fecal occult blood, experts said blood test checking colorectal cancer indicators can be primary measure for screening and those being found with alarming results should receive further colonscope for final diagnosis.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
